English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 25 June 2019, 19:00 JST
Share:
    

Source: Hacarus Inc.
DS Pharma Animal Health awards Hacarus the Grand Prize for 'New Business Solutions in Animal Health'

KYOTO, Japan, June 25, 2019 - (JCN Newswire) - Hacarus Inc, the leading provider of lightweight and explainable AI, was today awarded the Grand Prize by DS Pharma Animal Health for its innovative AI-enabled technology platform 'HACARUS.ai'.

"It is a great honor to receive this award for our work in creating technology that will improve animals' lives. Together with DS Pharma, we see a great opportunity to revolutionize animal health diagnostics with our AI technology, making treatment safer, faster and more humane," said Kenshin Fujiwara, CEO and Founder of Hacarus.

DS Pharma Animal Health is Japan's largest provider of animal health services, supporting some 11,000 animal hospitals and veterinarian clinics throughout the nation. It is also a market leader in the fields of companion animal-, livestock- and fisheries businesses. Through its 'New Business Search Program to Support Animal Health', DS Pharma is focused on finding the best leading-edge services and technologies that will help propel animal health, diagnostics and maintenance into the next century.

Amongst 18 project proposals shortlisted for innovation, impact and business potential, Hacarus was awarded the Grand Prize. The collaboration, aimed at bringing Hacarus Sparse Modeling-based AI tools to animal health diagnostics, sees DS Pharma and Hacarus working together on both a proprietary medical device and accompanying cloud services. Following a successful initial phase, the two companies will proceed towards a commercial partnership to provide AI enhanced animal health diagnostics in Japan and beyond.

About DS Pharma Animal Health Co., Ltd.

DS Pharma Animal Health is an R&D company established in July 2010 as a separate company from the business division of Sumitomo Dainippon Pharma Co., Ltd. Based on the experience and results gained through more than 70 years in the animal medicine business the company manufactures and markets pharmaceutical products for animals. In addition to medicines and functional foods, the company is expanding its business domain to the entire veterinary healthcare cycle - examinations, diagnoses, medicines and aftercare - and promoting transformation into a company that provides smart solutions. Please visit https://animal.ds-pharma.co.jp/.

About Hacarus

Hacarus Inc, founded in 2014 in Kyoto, Japan is the leading provider of explainable lightweight AI tools, backed by Miyako Capital (Kyoto University), among others. Its solutions are used in the medical and manufacturing fields to enable humans to make better, faster and more reliable decisions based on AI-driven insights. Hacarus' proprietary AI engine is built using 'Sparse Modeling', an AI method that understands data like a human would - by its unique key features - and is far more resource, time and energy efficient when compared to 'Deep Learning'. Please visit https://hacarus.com.

Topic: Awards
Source: Hacarus Inc.

Sectors: Healthcare & Pharm, Automation [IoT]
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
TransNusa Focuses on Organic Growth to Strengthen Network Connectivity in China  
Aug 11, 2025 23:55 HKT/SGT
Campaign to promote Hong Kong's advantages in professional services in Vietnam  
Aug 11, 2025 22:46 HKT/SGT
Shoucheng-Backed Data Center REITs Surge on Market Debut  
Aug 11, 2025 22:43 HKT/SGT
31 Concept to Debut Patent-Pending Technology at ISS Asia 2025 in Singapore  
Aug 11, 2025 22:42 HKT/SGT
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan  
Aug 11, 2025 22:39 HKT/SGT
Singapore's Digital Finance Model in Focus at the BFSI IT Summit - Singapore 2025  
Aug 11, 2025 18:26 HKT/SGT
WRC 2025: Shoucheng Showcases Full Robotics Value Chain  
Aug 11, 2025 16:27 HKT/SGT
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products  
Aug 11, 2025 10:41 HKT/SGT
Natural Beauty 2025 Interim Profit Surges by 136% to HK$11 Million  
Aug 11, 2025 08:15 HKT/SGT
Saudi Electricity Company Reports 22% Net Profit Growth in Q2 2025  
Aug 11, 2025 06:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575